http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-171229-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_024beee780595725c80afb468d9e8c21
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
filingDate 1993-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8092cc51a74f469c9639ef3d7944039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca0c720395dd990df63bfeb22ea039cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34dccf670328f77aab8e8c998490a6b9
publicationDate 1997-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-171229-B1
titleOfInvention A method of producing a new pharmaceutical preparation in the form of a semi-solid PL
abstract 1. The method of producing a new pharmacological preparation in a semi-solid form containing Acyclovir as the active substance, using sodium lauryl sulfate, glycerin and cetyl alcohol, characterized in that Acyclovir dissolves completely in 86% glycerins at 88 - 92 ° C by adding ß-phenylethyl alcohol, forming solution I, then an 8-10% aqueous solution of sodium lauryl sulfate is added to this solution to obtain solution II, which is then mixed with molten cetyl alcohol to form solution III, which in turn is gradually cooled with continuous mixing to 10 ° C until semi-solid form of the preparation is obtained. E N 171229 B 1 GB
priorityDate 1993-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488856
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415731158
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8697
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415789878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555458
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5363234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426080966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411832430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2682
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6054

Total number of triples: 46.